6 Result(s)

Article

A prospective study of intensive induction therapy with high-dose consolidation in patients with aggressive non-Hodgkin's lymphoma and two or three adverse prognostic factors

Patients with nhl and two or three factors of the international prognostic index (ipi) have a poor prognosis. we performed a prospective trial of intensive induction therapy followed with high-dose consolidati...

C Dumontet, C Thieblemont, D Espinouse, F Bouafia, O Hequet, G Salles… in Leukemia (2000)

Article

Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma

Bone Marrow Transplantation (2002) 29, 544. doi:10.1038/sj.bmt.1703383

O Hequet, C Dumontet, A El Jaafari-Corbin, G Salles… in Bone Marrow Transplantation (2002)

Article

Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma

High-dose melphalan (HDM) has been adopted as standard therapy in the treatment of multiple myeloma. This treatment is associated with non-selective cytotoxicity, causing oral mucositis as the major non-hemato...

C Thieblemont, C Dumontet, H Saad, N Roch, F Bouafia… in Bone Marrow Transplantation (2002)

Article

Autoimmune thrombocytopenic purpura after autologous stem cell transplantation

The pathogenesis of thrombocytopenia occurring after autologous stem cell transplantation (ASCT) remains unclear. Six cases of classical peripheral thrombocytopenia that developed after ASCT for non-Hodgkin's ...

O Hequet, G Salles, N Ketterer, D Espinouse, C Dumontet… in Bone Marrow Transplantation (2003)

Article

Allogeneic donor bone marrow cells recovery and infusion after allogeneic face transplantation from the same donor

O Hequet, J-P Bourgeot, M Michallet, E Morelon… in Bone Marrow Transplantation (2008)